Zobrazeno 71 - 80
of 145
pro vyhledávání: '"Muneer H. Abidi"'
Autor:
Lawrence G. Lum, Muneer H. Abidi, Abhinav Deol, Vidya Kondadasula, Voravit Ratanatharathorn, Lois Ayash, Divaya Bhutani, Joseph P. Uberti
Publikováno v:
Blood. 126:1902-1902
Background: Bortezomib has become an integral part of front-line therapy of multiple myeloma in a large majority of patients. There are preliminary reports which show that addition of bortezomib can augment the peripheral blood CD34 count during stem
Autor:
S. Vincent Rajkumar, Antje Hoering, Frederic J. Reu, Christopher M. Reynolds, Brian G.M. Durie, Mohan C. Thakuri, Joshua Epstein, Stephen P. Kahanic, Muneer H. Abidi, Bart Barlogie, Rachael Sexton, Robert Z. Orlowski, Angela Dispenzieri
Publikováno v:
Blood. 126:25-25
Background: Lenalidomide with dexamethasone (Rd) is a standard of care for patients with previously untreated multiple myeloma. SWOG S0777, a randomized phase III trial, has compared Rd with bortezomib, lenalidomide and dexamethasone (VRd). The prima
Autor:
Sandra Dixon, Peter M. Voorhees, P. Hari, Ralph V. Boccia, H. Wong, Claudia Paba Prada, P. G. Richardson, Kenneth H. Shain, Jeffrey A. Zonder, Muneer H. Abidi, Nashat Y. Gabrail, Linda Neuman
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:e273
Autor:
Judith Abrams, Muneer H. Abidi, Lois Ayash, Nishant Tageja, Joseph P. Uberti, Simon Cronin, Marie Ventimiglia, Zaid Al-Kadhimi, Lawrence G. Lum, Voravit Ratanatharathorn
This is a phase II trial evaluating efficacy and safety of Aprepitant (AP) in combination with 5-HT3 antagonist and adjusted dose dexamethasone in patients receiving high-dose cyclophosphamide (CY) and filgrastim for stem cell mobilization. We used S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b6f2c9aad2a9eaeeaf3ef65e7b808a2
https://europepmc.org/articles/PMC3594089/
https://europepmc.org/articles/PMC3594089/
Autor:
Lawrence G. Lum, Alice Mitchell, Abhinav Deol, Roberto Rodriguez, Joseph P. Uberti, Z. Gul, Lois Ayash, Muneer H. Abidi, Zaid Al-Kadhimi, Wei Chen, Voravit Ratanatharathorn
Publikováno v:
Biology of Blood and Marrow Transplantation. 17(2)
Autor:
Abhinav Deol, V. Rratanatharathorn, Lawrence G. Lum, Z. Gul, M. Abdul-Hussein, Joseph P. Uberti, Zaid Al-Kadhimi, Muneer H. Abidi, Lois Ayash, Ivo Ditah
Publikováno v:
Biology of Blood and Marrow Transplantation. 17(2)
Autor:
Jerzy Holowiecki, Dzhelil Osmanov, Craig H. Moskowitz, John W. Sweetenham, Angelo Michele Carella, Alessandro Gianni, Patrick J. Stiff, Andy I. Chen, Jan Walewski, Yin Yang, Tamas Masszi, Dirk Huebner, Edward Agura, Auayporn Nadamanee, Naomi N. H. Hunder, Anna Sureda, Muneer H. Abidi
Publikováno v:
Biology of Blood and Marrow Transplantation. 20(2):S115-S116
Autor:
Shaji Kumar, Robert A. Kyle, Robert Peter Gale, David H. Vesole, Peter H. Wiernik, Christopher Bredeson, Smriti Shrestha, Hillard M. Lazarus, Asad Bashey, Gustavo Milone, Muneer H. Abidi, Philip L. McCarthy, James Gajewski, Harold L. Atkins, Gregory A. Hale, John Gibson, Waleska S. Pérez, Willem Bujan Boza, Donna E. Reece, Mei-Jie Zhang, Cesar O. Freytes, Vivek Roy, Daniel J. Weisdorf, Parameswaran Hari, Santiago Pavlovsky, Angela Dispenzieri
Publikováno v:
Clinical lymphoma, myelomaleukemia. 10(6)
Immunoglobulin D (IgD) and IgM multiple myeloma represent uncommon immunoglobulin isotypes, accounting for 2% and 0.5% of cases, respectively. Limited information is available regarding the prognosis of these isotypes, but they have been considered t
Autor:
Jeffrey A. Zonder, Dennis F. Moore, Bart Barlogie, Vanessa Bolejack, Brian G.M. Durie, Muneer H. Abidi, Brock F. Whittenberger, Mohamad A. Hussein, John Crowley
Publikováno v:
Blood. 116(26)
The Southwest Oncology Group conducted a randomized trial comparing lenalidomide (LEN) plus dexamethasone (DEX; n = 97) to placebo (PLC) plus DEX (n = 95) in newly diagnosed myeloma. Three 35-day induction cycles applied DEX 40 mg/day on days 1 to 4,
Autor:
Lois Ayash, Zaid Al-Kadhimi, Lawrence G. Lum, Joseph P. Uberti, Archana Thakur, Francis J. Cummings, Ritesh Rathore, Voravit Ratanatharathorn, Muneer H. Abidi
Publikováno v:
Biology of Blood and Marrow Transplantation. 16(2)